What should you know about lung cancer nsclc adenocarcinoma?

Adenocarcinoma is identified by examining cells, usually from a biopsy or a surgical sample. The pathology report describes the tumour type and may include additional features. Staging then assesses the tumour, nearby lymph nodes, and possible spread, including to the brain or other organs. These details help the team discuss whether treatment is local, systemic, or combined.

Genomic tumour profiling may look for changes that can guide targeted treatment. Depending on the findings, options may include surgery such as lung lobectomy, radiotherapy, chemotherapy, immunotherapy, or targeted medicines. Palliative care can help manage breathlessness, pain, fatigue, and other concerns at any stage.

Request an explanation of the pathology report in everyday language. Ask whether the biopsy is sufficient for molecular testing, which scans are needed for staging, and what the goal of each proposed treatment is. Keep a written list of medicines and symptoms, and bring a support person if that helps you remember information.

Get urgent medical help for severe breathing difficulty, coughing blood, chest pain with faintness, a seizure, sudden weakness, new confusion, or rapidly worsening symptoms. During treatment, use the cancer team’s urgent contact route for fever, inability to keep fluids down, or a sudden decline in function.

Ask what confirms adenocarcinoma, what stage has been assigned, whether molecular results are available, and how those results change the options. Ask about the expected schedule, common effects, monitoring scans, fertility or work concerns, and how palliative care can support you.